Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year free cash flow growth rate
Percentile
P74
Within normal range
vs 2Y Ago
2.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 27.98% |
| Q3 2025 | 1.92% |
| Q2 2025 | 28.95% |
| Q1 2025 | 36.35% |
| Q4 2024 | -56.45% |
| Q3 2024 | -165.68% |
| Q2 2024 | -307.64% |
| Q1 2024 | 152.50% |
| Q4 2023 | 12.00% |
| Q3 2023 | -19.82% |
| Q2 2023 | 13.07% |
| Q1 2023 | -231.24% |
| Q4 2022 | -61.68% |
| Q3 2022 | 38.15% |
| Q2 2022 | -106.91% |
| Q1 2022 | -3.87% |
| Q4 2021 | 34.80% |
| Q3 2021 | -73.40% |
| Q2 2021 | -72.69% |
| Q1 2021 | 12.93% |
| Q4 2020 | -81.82% |
| Q3 2020 | 48.34% |
| Q2 2020 | 3.64% |
| Q1 2020 | 34.54% |
| Q4 2019 | -84.29% |
| Q3 2019 | 30.20% |
| Q2 2019 | 26.60% |
| Q1 2019 | -19.67% |
| Q4 2018 | 29.03% |
| Q3 2018 | -11.07% |
| Q2 2018 | -33.85% |
| Q1 2018 | 28.29% |
| Q4 2017 | 5.60% |
| Q3 2017 | -16.75% |
| Q2 2017 | 4.55% |
| Q1 2017 | 12.21% |
| Q4 2016 | -16.87% |
| Q3 2016 | -4.35% |
| Q2 2016 | -48.64% |
| Q1 2016 | -14.90% |